May 21 |
Lilly partners with Aktis, deepening radiopharma investment
|
May 21 |
Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds
|
May 21 |
Eli Lilly inks radiopharma deal worth up to $1.1B with Aktis
|
May 21 |
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure
|
May 21 |
Eli Lilly’s tirzepatide cleared for diabetes treatment in China
|
May 21 |
Eli Lilly's diabetes drug tirzepatide gets approval in China
|
May 20 |
Magnificent Seven? Just Two Members Clear This Bar
|
May 20 |
The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Costco and Koss
|
May 20 |
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
|
May 19 |
SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?
|